Olivier Sitbon

54.9k total citations · 12 hit papers
460 papers, 27.7k citations indexed

About

Olivier Sitbon is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, Olivier Sitbon has authored 460 papers receiving a total of 27.7k indexed citations (citations by other indexed papers that have themselves been cited), including 430 papers in Pulmonary and Respiratory Medicine, 203 papers in Cardiology and Cardiovascular Medicine and 107 papers in Genetics. Recurrent topics in Olivier Sitbon's work include Pulmonary Hypertension Research and Treatments (420 papers), Cardiovascular Issues in Pregnancy (113 papers) and Vascular Anomalies and Treatments (96 papers). Olivier Sitbon is often cited by papers focused on Pulmonary Hypertension Research and Treatments (420 papers), Cardiovascular Issues in Pregnancy (113 papers) and Vascular Anomalies and Treatments (96 papers). Olivier Sitbon collaborates with scholars based in France, United States and Canada. Olivier Sitbon's co-authors include Gérald Simonneau, Marc Humbert, Xavier Jaïs, David Montani, Florence Parent, Philippe Hervé, Laurent Savale, Lewis J. Rubin, Richard N. Channick and Victor F. Tapson and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Olivier Sitbon

427 papers receiving 27.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pulmonary Arterial Hypertension in France

2006 1.4k citations Marc Humbert, Olivier Sitbon et al. profile →
Treatment of Pulmonary Arterial Hypertension

2004 1.3k citations Marc Humbert, Olivier Sitbon et al. profile →
Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebocontrolled study

2001 1.1k citations Richard N. Channick, G Simonneau et al. profile →
Long-term intravenous epoprostenol infusion in primary pulmonary hypertension

2002 1.0k citations Olivier Sitbon, Marc Humbert et al. profile →
Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension

2013 948 citations Tomás Pulido, Richard N. Channick et al. profile →
Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension

2005 797 citations Olivier Sitbon, Marc Humbert et al. Circulation profile →
Diagnosis and differential assessment of pulmonary arterial hypertension

2004 731 citations Adam Torbicki, Olivier Sitbon et al. profile →
Selexipag for the Treatment of Pulmonary Arterial Hypertension

2015 706 citations Olivier Sitbon, Richard N. Channick et al. profile →
Increased Interleukin-1 and Interleukin-6 Serum Concentrations in Severe Primary Pulmonary Hypertension

1995 622 citations Marc Humbert, Olivier Sitbon et al. profile →
Survival in incident and prevalent cohorts of patients with pulmonary arterial hypertension

2010 470 citations Marc Humbert, Olivier Sitbon et al. European Respiratory Journal profile →
Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension

2017 441 citations Athénaïs Boucly, Jason Weatherald et al. European Respiratory Journal profile →
Treatment algorithm for pulmonary arterial hypertension

2024 50 citations Olivier Sitbon et al. European Respiratory Journal profile →

Peers

Countries citing papers authored by Olivier Sitbon

Since Specialization

Citations

This map shows the geographic impact of Olivier Sitbon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivier Sitbon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivier Sitbon more than expected).

Fields of papers citing papers by Olivier Sitbon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivier Sitbon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivier Sitbon. The network helps show where Olivier Sitbon may publish in the future.

Co-authorship network of co-authors of Olivier Sitbon

This figure shows the co-authorship network connecting the top 25 collaborators of Olivier Sitbon. A scholar is included among the top collaborators of Olivier Sitbon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivier Sitbon. Olivier Sitbon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	International Liver Transplantation Society practice guideline update on portopulmonary hypertension 2025 ·Liver Transplantation ·Hilary M. DuBrock, Laurent Savale, Olivier Sitbon, Sarah Raevens, Steven M. Kawut, Marie Fallon, Julie K. Heimbach, Ryan Chadha, Gonzalo Crespo, Michael A. E. Ramsay, Michael J. Krowka	2
2	Risk stratification in Eisenmenger syndrome 2025 ·Archives of cardiovascular diseases ·(unknown), Athénaïs Boucly, Marc Humbert, Olivier Sitbon, Laurent Savale, David Montani, Jérôme Le Pavec, Élie Fadel, Magalie Ladouceur, Emmanuelle Fournier, (unknown), (unknown), (unknown), Alain Fraisse, Michael Α. Gatzoulis, Aleksander Kempny, Sébastien Hascoët	1
3	Drugs targeting novel pathways in pulmonary arterial hypertension 2025 ·European Respiratory Journal ·Olivier Sitbon, Athénaïs Boucly, Jason Weatherald, Fabrice Antigny, Christophe Guignabert, Mitja Jevnikar, Xavier Jaïs, Laura Price, Martin R. Wilkins, Roham T. Zamanian, Laurent Savale, David Montani, Marc Humbert	2
4	Outcomes and risk assessment in pulmonary veno-occlusive disease 2024 ·ERJ Open Research ·Athénaïs Boucly, (unknown), Antoine Beurnier, Xavier Jaïs, (unknown), Mélanie Eyries, Andrei Seferian, Mitja Jevnikar, Anne Roche, Sophie Bulifon, Arnaud Bourdin, Ari Chaouat, Vincent Cottin, Laurent Bertoletti, Laurent Savale, Marc Humbert, Olivier Sitbon, David Montani	7
5	Placental growth factor modulates endothelial NO production and exacerbates experimental hepatopulmonary syndrome 2024 ·JHEP Reports ·F. Robert, (unknown), Mina Ha, Alessandra Cuomo, (unknown), (unknown), Raphaël Thuillet, Corinne Normand, Florent Dumont, Céline Verstuyft, Frédéric Di Fiore, (unknown), Marc Humbert, Audrey Coilly, Emmanuel Gonzalès, Olivier Sitbon, Ly Tu, Christophe Guignabert, Laurent Savale	1
6	Therapeutic Implications of Plasma Proteome Clusters in Pulmonary Hypertension 2024 ·(unknown), Luke Howard, (unknown), Olivier Sitbon, Dennis Wang, Allan Lawrie, Christopher J. Rhodes, Martin R. Wilkins	0
7	Pulmonary veno-occlusive disease: illustrative cases and literature review 2024 ·European Respiratory Review ·Benoît Lechartier, Athénaïs Boucly, (unknown), Deepa Gopalan, Peter Dorfmüller, Teodora Radonic, Olivier Sitbon, David Montani	10
8	The Influence of Methods for Cardiac Output Determination on the Diagnosis of Precapillary Pulmonary Hypertension: A Mathematical Model 2023 ·Journal of Clinical Medicine ·(unknown), (unknown), (unknown), Julie Wacker, Silvia Ulrich, Benoît Lechartier, Jean‐Marc Fellrath, Olivier Sitbon, Maurice Beghetti, Frédéric Lador	0
9	ERS International Congress 2023: highlights from the Pulmonary Vascular Diseases Assembly 2023 ·ERJ Open Research ·Sarah Cullivan, Athénaïs Boucly, Mitja Jevnikar, Benoît Lechartier, Silvia Ulrich, Laurent Bertoletti, Olivier Sitbon, Anton Vonk Noordegraaf, (unknown), (unknown), (unknown), Julien Guiot, Étienne-Marie Jutant, Lucilla Piccari, Mona Lichtblau	1
10	ERS International Congress 2021: highlights from the Pulmonary Vascular Diseases Assembly 2022 ·ERJ Open Research ·Mona Lichtblau, Lucilla Piccari, (unknown), (unknown), Benoît Lechartier, Étienne-Marie Jutant, (unknown), (unknown), Luke Howard, Yochai Adir, Marion Delcroix, Luis Jara‐Palomares, Laurent Bertoletti, Olivier Sitbon, Silvia Ulrich, Anton Vonk Noordegraaf	1
11	Outcomes of patients with decreased arterial oxyhaemoglobin saturation on pulmonary arterial hypertension drugs 2021 ·European Respiratory Journal ·Simon Valentin, (unknown), Olivier Sitbon, Antoine Beurnier, E. Gomez, Anne Guillaumot, (unknown), Renaud Fay, Laurent Savale, Xavier Jaïs, David Montani, François Picard, Jean‐François Mornex, Grégoire Prévôt, F. Chabot, Marc Humbert, Ari Chaouat	11
12	External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registry 2021 ·European Respiratory Journal ·Athénaïs Boucly, Jason Weatherald, Laurent Savale, Pascal de Groote, Vincent Cottin, Grégoire Prévôt, Ari Chaouat, François Picard, Delphine Horeau-Langlard, Arnaud Bourdin, Étienne-Marie Jutant, Antoine Beurnier, Mitja Jevnikar, Xavier Jaïs, Gérald Simonneau, David Montani, Olivier Sitbon, Marc Humbert	100
13	Current and future treatments of pulmonary arterial hypertension 2020 ·British Journal of Pharmacology ·Natascha Sommer, Hossein Ardeschir Ghofrani, Oleg Pak, Sébastien Bonnet, S. Provencher, Olivier Sitbon, Stephan Rosenkranz, Marius M. Hoeper, David G. Kiely	118
14	Klippel-Trenaunay syndrome as a rare cause of chronic thromboemboembolic pulmonary hypertension 2019 ·Respiratory Medicine and Research ·Andrei Seferian, Xavier Jaïs, (unknown), Mitja Jevnikar, Maria‐Rosa Ghigna, Jason Weatherald, Sandra Assoun, (unknown), G Simonneau, Olivier Sitbon, Marc Humbert, David Montani	5
15	Chronic blood exchange transfusions in the management of pre-capillary pulmonary hypertension complicating sickle cell disease 2018 ·European Respiratory Journal ·Matthieu Turpin, (unknown), Florence Parent, Françoise Driss, François Lionnet, Anoosha Habibi, Bernard Maître, Alice Huertas, Xavier Jaïs, Jason Weatherald, David Montani, Olivier Sitbon, Gérald Simonneau, Frédéric Galactéros, Marc Humbert, Pablo Bartolucci, Laurent Savale	17
16	Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension 2017 ·Circulation ·Jason Weatherald, Athénaïs Boucly, D. S. Chemla, Laurent Savale, Mingkai Peng, Mitja Jevnikar, Xavier Jaïs, Yu Taniguchi, Caroline O’Connell, Florence Parent, C.H. Sattler, Philippe Hervé, Gérald Simonneau, David Montani, Marc Humbert, Yochai Adir, Olivier Sitbon	141
17	Kinetics of Cardiac Output at the Onset of Exercise in Precapillary Pulmonary Hypertension 2016 ·BioMed Research International ·Frédéric Lador, Aurélien Bringard, (unknown), Guido Ferretti, Karim Bendjelid, Paola M. Soccal, Stéphane Noble, Maurice Beghetti, D. S. Chemla, Philippe Hervé, Olivier Sitbon	7
18	Effect of macitentan on haemodynamics in SERAPHIN, a randomised controlled trial in pulmonary arterial hypertension (PAH) 2013 ·European Respiratory Journal ·Olivier Sitbon, Richard N. Channick, Marion Delcroix, Nazzareno Galiè, Hossein Ardeschir Ghofrani, Pavel Jansa, Franck‐Olivier Le Brun, Sanjay Mehta, Loı̈c Perchenet, Tomás Pulido, (unknown), Rogério Souza, Adam Torbicki, Lewis J. Rubin, Gérald Simonneau	5
19	Diagnostic et prise en charge de l’hypertension pulmonaire en 2009. Commentaires sur les nouvelles recommandations de l’European Society of Cardiology (ESC) et de l’European Respiratory Society (ERS) 2010 ·Revue des Maladies Respiratoires ·Olivier Sanchez, Marc Humbert, Olivier Sitbon, Xavier Jaïs, G. Simonneau	7
20	Hypertension artérielle pulmonaire primitive et infection par le VIH 1999 ·Sang thrombose vaisseaux ·Hilario Nunès, Marc Humbert, (unknown), Olivier Sitbon, Philippe Hervé, Gérald Simonneau	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact